Exciting patient trial for patients with MND
A new Fellow, based at the Flinders Motor Neurone Disease (MND) Clinic, will oversee an exciting patient trial investigating the effectiveness of a drug combination used to treat HIV in slowing the progression of MND.
Dr Alexandra Thompson has been appointed as the new Julie Lawrence MND Fellow at Flinders and will be involved in a worldwide trial called ‘Lighthouse II’, led by Professor Julian Gold of Macquarie University, Sydney.
Lighthouse II is the first phase three clinical trial in the world to use modern combination anti-retroviral therapy in patients with MND.
The COVID-19 pandemic slowed a lot of research across the world, and Dr Thompson said it was pleasing to get the third phase of the trial underway.
“Lighthouse II is a trial that involves people, it’s not just looking at drugs in a lab. It’s looking at whether a very well-known and frequently used combination of common anti-retroviral drugs used in HIV can have any impact on MND,” Dr Thompson said.
“The trial is based on interesting research about some viruses that have been integrated into the human genome over millions of years, which are thought to be retroviruses similar to HIV. It’s a placebo versus real drug trial and we’ll be following the patients for two years to see whether it has any impact on quality of life, symptoms, and survival.”
Established in memory of Dr Julie Lawrence – the first female plastic surgeon in South Australia – who passed away from MND in 2019, the fellowship will support Dr Thompson to care for people and their families living with MND and progress research at South Australia’s sole MND clinic.
Julie’s husband Steve and brother Graham made this fellowship possible, donating to the Motor Neurone Disease Association of South Australia (MNDSA) who have partnered with Flinders Foundation and the Flinders Medical Centre Clinician’s Special Purpose Fund.
Dr Thompson is extremely grateful to receive the fellowship, which will incorporate patient care and research.
“It’s not a matter of the funding making it easier, it’s the difference between the research happening or not. Being able to fund a Fellow, like myself, as well as research coordinators, study coordinators, and research nurses is the only way it can work. It’s imperative and central to the wheels turning. It’s more than just important, it’s essential.”
“I’ve supported several patients with MND before, but only intermittently throughout my years of physician training, so to be able to come to a speciality clinic is a real privilege and something I’m very excited to be a part of,” Dr Thompson said.
“It’s also a great opportunity to get involved in research, which is something we all strive to do in our training, but it can be challenging finding opportunities or finding time to be involved in research.
“To be at a place where research is a central part of the day-to-day workings of the MND clinic, and planning for multiple trials on the horizon is fantastic. It’s great for my learning and experience, but most of all it’s fantastic for the patients.”
Dr Thompson will work closely with respected Flinders Medical Centre Neurologist A/Prof David Schultz, who is an experienced clinical trials physician and well-published in many areas within Neurology including MND.
Dr Thompson said research such as this wouldn’t be possible without generous supporters, like Julie’s husband Steve and brother Graham.
Brett’s Hope for Brain Cancer Breakthrough
Three years ago, Dr Brett Stringer arrived at Flinders to work on an idea to help improve survival for patients with the deadliest form of brain cancer – glioblastoma.
The healing sounds of music
Thanks to the generosity of Flinders Foundation supporters and a CommBank Staff Foundation Community Grant, elderly and palliative patients, as well as those undergoing rehabilitation, have been being entertained, soothed and moved by a variety of visiting musicians through a new ‘Music Matters’ program.
Panthers roar with Flinders Foundation
An exciting partnership has been launched between South Adelaide Football Club and Flinders Foundation for the benefit of the Southern Adelaide community.
New PET scan hope for ‘tricky’ tumours
“Groundbreaking” work out of Flinders is aiming to help doctors visualise ‘tricky’ tumours not visible on PET scans to help them make important cancer treatment decisions.
2023 Flinders Foundation Health Seed Grant Round now open
Flinders Foundation, with support from Flinders University, is proud to open the 2023 Flinders Foundation Health Seed Grant Round supporting health and medical research.
A novel blood test which could be used to monitor the treatment of lung cancer
Flinders Medical Centre Senior Consultant, Dr Anand Rose, has received a Southern Adelaide Local Health Network (SALHN) Enquiry Grant for research into a novel blood test which could be used to monitor the treatment of lung cancer – the most common cause of cancer-related death in Australia.
Stroke Rehab goes Virtual
Researchers from Flinders University and UniSA are set to develop a new rehabilitation technique for stroke survivors using state-of-the-art Virtual Reality (VR) technology.
New Hope for Pancreatic Cancer
Dr Jean Winter and her Flinders University research team will soon begin trials of a world-first blood biomarker test for patients with pancreatic cancer.
Help for families in gambling battle
The Southern Adelaide Local Health Network’s (SALHN) Statewide Gambling Therapy Service provides psychological therapies to individuals with gambling addictions.
Rapid access to surgical procedures
Podiatrists at Noarlunga Hospital will trial a new model of care for anxious patients, to help them get rapid access to some minor surgical procedures.